 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/12/2024 |
$0.16 |
$0.17 |
$0.16 |
$0.17 |
199.40K | | 04/15/2024 |
$0.17 |
$0.17 |
$0.16 |
$0.16 |
172.30K | | 04/16/2024 |
$0.16 |
$0.17 |
$0.16 |
$0.16 |
150.20K | | 04/17/2024 |
$0.17 |
$0.17 |
$0.16 |
$0.16 |
272.90K | | 04/18/2024 |
$0.17 |
$0.18 |
$0.16 |
$0.17 |
431.00K |
|
|
| ReShape Lifesciences is a weight-loss solutions company, providing a portfolio of products and services that manage and treat obesity and associated metabolic disease. Co.'s primary operations are in the following geographical areas: U.S., Australia and certain European and Middle Eastern countries. Co.'s portfolio includes the Lap-Band Adjustable Gastric Banding System, the reshapecare virtual health coaching program, the ReShape Marketplace, the Obalon Balloon System, the ReShape Vest, an investigational device to help treat more patients with obesity, and the Diabetes Bloc-Stim Neuromodulation device, a technology under development as a new treatment for type 2 diabetes mellitus. | |
|
ReShape Lifesciences (RSLS) has the following price history information. Looking back at RSLS historical stock prices for the last five trading days, on April 12, 2024, RSLS opened at $0.16, traded as high as $0.17 and as low as $0.16, and closed at $0.17. Trading volume was a total of 199.40K shares. On April 15, 2024, RSLS opened at $0.17, traded as high as $0.17 and as low as $0.16, and closed at $0.16. Trading volume was a total of 172.30K shares. On April 16, 2024, RSLS opened at $0.16, traded as high as $0.17 and as low as $0.16, and closed at $0.16. Trading volume was a total of 150.20K shares. On April 17, 2024, RSLS opened at $0.17, traded as high as $0.17 and as low as $0.16, and closed at $0.16. Trading volume was a total of 272.90K shares. On April 18, 2024, RSLS opened at $0.17, traded as high as $0.18 and as low as $0.16, and closed at $0.17. Trading volume was a total of 431.00K shares.
RSLS Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into ReShape Lifesciences shares, starting with a $10,000 purchase of RSLS, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
10/07/2016 |
|
| End date: |
04/18/2024 |
|
| Start price/share: |
$1,575,000.00 |
|
| End price/share: |
$0.17 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-100.00% |
|
| Average Annual Total Return: |
-88.10% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$0.00 |
|
| Years: |
7.53 |
|
|
|
| Date |
Close |
| 04/12/2024 | $0.17 | | 04/15/2024 | $0.16 | | 04/16/2024 | $0.16 | | 04/17/2024 | $0.16 | | 04/18/2024 | $0.17 |
|
|
Free RSLS Email Alerts:
